Phenomix Sciences
Genomics & Genetic Testing
$9.7Mtotal raised · 5 rounds on record
$2.5Mlatest round · Venture round · Dec 2025 · 10 mo ago
$2Mgrants · 1 grant · CORDIS
10team · US Form 5500 (plan participants) · Dec 2025
Overview
Phenomix Sciences uses AI for precision obesity medicine integrating genetic, clinical, and biomarker data. Deliver the right intervention at the right time.
Funding and backers
Total raised
$9.7M
5 rounds on record
Latest round
$2.5M
Venture round · Dec 2025 · 10 mo ago
Team
10
US Form 5500 (plan participants) · Dec 2025
Grants
$2M
1 grant · CORDIS
The money's age
Fresh money
10 months since the last round · not hiring
Momentum
20/100
fresh money
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jun 16
Launched Phenomix Sciences Launches MyPhenome Test Directly to Patients to Help Guide Weight Loss Treatment Based on Biology · morningstar.com
Dec 23, 2025
Raised a round Venture round $2.5M · SEC Form D
Apr 8, 2025
Launched Phenomix Sciences Launches Clinical Trial to Predict GLP-1 Response · hitconsultant.net
Apr 4, 2024
Launched Phenomix Sciences Launches 3-in-1 Obesity Phenotyping Test · hitconsultant.net
Mar 15, 2024
Won a grant $2M · CORDIS
Mar 30, 2023
Launched Phenomix Sciences Launches First-of-its-Kind Test to Predict Obesity Phenotype Resulting in Precision Medicine Treatment Options · PRNewswire
Feb 8, 2023
Raised a round Venture round $1M · SEC Form D
May 17, 2018
Raised a round Convertible Note $1.1M · SEC Form D
2017
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Dec 2025 | $2.5M | — | SEC Form D |
| Venture round | Apr 2024 | $5M | — | SEC Form D |
| Grant | Mar 2024 | $2M | — | CORDIS |
| Venture round | Feb 2023 | $1M | — | SEC Form D |
| Convertible Note | May 2018 | $1.1M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Phenomix Sciences LLC | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Andres AcostaDirectorSEC Form D
William HigginsExecutive OfficerSEC Form D
Mark BagnallExecutive Officer, DirectorSEC Form D
Mark BengallExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Advancing precision neurology through brain-derived circular RNA, blood-based biomarkers, and molecular intelligence for neuroscience…
Turn your data into genetic insights and get answers for your most complex cases at scale through fast and automated HPO-driven variant…
Enhanced Genomics is redefining how medicines are discovered by revealing the causal biology behind genetic variation. Our integrated 3D…
ChromaCode is a leading provider of HDPCR™ multiplexing technology for genomic solutions. Our breakthrough platform enables labs…
3X4 Genetics offers DNA genetic testing that tells you everything you need to know about your body. Learn how to manage your health with…
Detect Early, Live Fully. Our mission at OrisDX is to leverage salivary rinse samples to detect disease early and guide people to early…
Financials
Total raised
$11.6M
Latest round
Venture - Series Unknown
Funding rounds
5
People
Andres Acosta
Director
William Higgins
Executive Officer
Mark Bagnall
Executive Officer, Director
Mark Bengall
Executive Officer, Director
Paul Owen
Director
Michael Camilleri
Director
Sean McCauley
Director
Karl Ronn
Director
Lawrence Cohen
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
News
Phenomix Sciences Launches MyPhenome Test Directly to Patients to Help Guide Weight Loss Treatment Based on Biology
Phenomix Sciences (Phenomix), the first commercial precision obesity medicine biotechnology company, today announced that patients can now order the MyPhenome genetic obesity test directly through the company
Read more
Report
Phenomix Sciences Launches MyPhenome Test Directly to Patients to Help Guide Weight Loss Treatment Based on Biology
Read more
Report
More Than Half of GLP-1 Users Reported Seeking Follow-Up Care for Side Effects, Phenomix Sciences Report Finds
In recognition of Obesity Care Week, Phenomix Sciences (Phenomix), the first commercial precision obesity medicine biotechnology company, today released new findings from its "2026 State of Obesity Treatment Report: Progress, Gaps, and the Path to Persona
Read more
Report
Phenomix Sciences
The Nature Index tracks the affiliations of scientific articles from high-quality publications. The research profile for Phenomix Sciences reflects the research output of authors from Phenomix Sciences who published articles in the 145 journals included i
Read more
Report
Phenomix Sciences Launches Clinical Trial to Predict GLP-1 Response
Phenomix Sciences Launches Clinical Trial to Predict GLP-1 Response Using Precision Obesity Test ensuring GLP-1 medications are prescribed...
Read more
Report
Hello Alpha, Phenomix Sciences Launch Partnership for Genetic Obesity Test
A new partnership will give Hello Alpha patients access to Phenomix Sciences' genetic obesity test.
Read more
Report
Phenomix Sciences: $7.8 Million Raised To Bring Data Intelligence To Obesity Treatment
Phenomix Sciences, a precision medicine biotechnology company bringing data intelligence to the treatment of obesity, announced it raised $5.5 million in Series A funding from new investors, DexCom and Labcorp, and existing investors, including Health2047
Read more
Report
Phenomix Sciences Launches 3-in-1 Obesity Phenotyping Test
Phenomix Sciences launches a new MyPhenome test that identifies all three key obesity phenotypes in a single test.
Read more
Report
Phenomix Sciences Launches First-of-its-Kind Test to Predict Obesity Phenotype Resulting in Precision Medicine Treatment Options
/PRNewswire/ -- With forecasts predicting that obesity drug sales will quadruple in the next five years to $11B annually, it is crucial for providers to know...
Read more
Report
Show more news
Offices
Where the company hires and what each office is for
Cities
2
Hiring now
0
Countries
1
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
Saint Paul
United States
HQ
Wayzata
United States
HQ
Contact
18202 Minnetonka Blvd, Wayzata, MN 55391-3343